GENOME PHARMACEUTICALS INSTITUTE
GENOME PHARMACEUTICALS INSTITUTE
Industry:
Biotechnology Pharmaceutical
Founded:
2000-12-21
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.genome-pharm.jp
Status:
Active
Contact:
+81 3 5684 8570
Technology used in webpage:
SPF Google Analytics Google Universal Analytics Apache Google Analytics Classic GlobalSign AlphaSSL
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.genome-pharm.jp
- Host name: sv122.wadax-sv.jp
- IP address: 153.123.7.87
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Genome Pharmaceuticals Institute"
member ｜ Genome Pharmaceuticals Institute
Kimihito Usui is Senior Researcher of Genome Pharmaceuticals Institute Co., Ltd. since 2015. He holds Ph.D. in Graduate School of Pharmaceutical Sciences, The University of Tokyo.See details»
Genome Pharmaceuticals Institute - Crunchbase
Where is Genome Pharmaceuticals Institute's headquarters? Genome Pharmaceuticals Institute is located in Tokyo, Tokyo, Japan. Who are Genome Pharmaceuticals Institute's competitors? …See details»
GENOME PHARMACEUTICALS INSTITUTE - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GENOME PHARMACEUTICALS INSTITUTE of BUNKYO-KU, TOKYO. Get the latest business insights …See details»
Genome Pharmaceuticals Institute Co. Ltd. - CB Insights
About Genome Pharmaceuticals Institute Co. Ltd. Genome Pharmaceuticals Institute Co. Ltd. is a biotechnology company focused on the development of pharmaceuticals and functional foods …See details»
OUR COMPANY - Genome Pharmaceuticals
Genome is a group of companies with a major interest in pharmaceuticals and allied fields. The company head office is located in Islamabad, the capital city of Pakistan, in close collaboration with the related legal authorities. Genome's …See details»
research results ｜ Genome Pharmaceuticals Institute
Asami Y, Horie R, Hamamoto H, Sekimizu K:Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources. BMC Pharmacol.11;10:7, (2010) …See details»
topics research ｜ Genome Pharmaceuticals Institute～ゲノム創薬 …
Reserch Themes For details, please contact at telephone +81-3-5684-8570 1.Development of Novel Antibacterial Therapeutics In general, a pharmaceutical industry use mammals such as …See details»
World of Genomics: Japan
Aug 15, 2023 It includes pathological genome variants for a range of diseases and HLA allele frequencies. Genome Medical Alliance Japan (GEM Japan): A Global Alliance for Genomics and Health driver project, GEM Japan aims to …See details»
MHLW Unveils Overview of Genome Analysis Project …
Nov 17, 2022 The Ministry of Health, Labor and Welfare (MHLW) on November 15 announced an overview of an organization it will set up in FY2025 to implement the government’s action plan for whole genome analysis. The …See details»
home - Greater Tokyo Biocommunity - JBA
Japan Bioindustry Association (JBA) and NPO Kinki Bio-Industry Development Organization (KBDO) jointly publish and manage “Japanese Life Science Startup List,” a database to …See details»
Patents | Genome Pharmaceuticals Institute
Issued - Nov 20, 2012 Genome Pharmaceuticals Institute Co., Ltd., the University of Tokyo and Imagine Global Care Corporation,See details»
GenAhead Bio Inc.
Our company provides highly efficient genome editing services and technology for delivering nucleic acids to the tissues. We offer flexible genome editing services based on our …See details»
The Whole Genome Sequence of 100,000 Japanese General
Jun 20, 2024 Roadmap For this achievement, we follow a government plan and a consortium of five pharmaceutical companies, established in March 2021, has significantly support us. It is …See details»
Inocras and Summit Pharmaceuticals International Corporation …
Nov 6, 2024 Inocras is an AI-driven company that specializes in delivering critical insights to cancer and rare disease patients through whole genome sequencing. The company offers its …See details»
Whole genome analysis of 100,000 Japanese people to serve as …
Jul 30, 2024 Masayuki Yamamoto, Executive Director of ToMMo, said, "The whole genome analysis of 100,000 people was accomplished with tremendous support from the government …See details»
Study Group of Lawmakers, Industry Urges Earlier Launch of …
Jul 3, 2023 Discussions have been underway to launch an organization in FY2025 to implement Japan’s whole genome analysis action plan, but this target should be moved up by at least …See details»
The SCC Participates in the Research Project for Whole Genome …
Over the past 8 years, about 9,000 cancer cases have been analyzed for entire exon in the Project HOPE, which has led to the development of the Pharma Valley Project as well as the …See details»
Gene therapy for age-related macular degeneration: a promising …
1 day ago Age-related macular degeneration (AMD) is a leading cause of central vision loss, progressively impairing the retina and affecting millions worldwide. By 2040, global cases of …See details»
Japan Diet Enacts Genomic Medicine Promotion Bill
Jun 12, 2023 Japan’s Diet passed into law a lawmaker-sponsored genomic medicine promotion bill by a majority vote at an Upper House plenary session on June 9.Based on the law, the …See details»
joint research ｜ Genome Pharmaceuticals Institute
Joint Research with Masis, Inc. In cooperation with Masis, Inc., we are pursuing the establishment and commercialization of the methods to detect toxic and pathogenic substances contained in …See details»